tetramethylpyrazine has been researched along with cyclic gmp in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, WF; Wu, CC; Yen, MH | 1 |
| Li, YJ; Wu, JX; Yan, YF; Yu, XJ | 1 |
| Hung, WC; Kan, YC; Lin, CH; Sheu, JR; Yen, MH | 1 |
| Luo, R; Yan, F | 1 |
| Chen, J; Chen, Z; Fan, L; Liu, J; Wang, T; Xiao, H; Ye, Z; Yin, C | 1 |
| Huang, WC; Lai, TY; Liou, SS; Liu, IM; Tsai, CC | 1 |
| Gao, C; Li, J; Liu, X; Shao, Z; Sun, Z; Zhao, Z | 1 |
| Gui, C; Huang, K; Huang, Q; Huang, X; Wei, B; Yu, L | 1 |
| Deng, H; Luo, J; Shan, L; Wang, Y; Xu, B; Zhang, G; Zhang, X; Zhang, Z | 1 |
1 review(s) available for tetramethylpyrazine and cyclic gmp
| Article | Year |
|---|---|
[Effects of ligustrazine on blood vessels and blood components].
Topics: Animals; Calcium Channel Blockers; Cell Division; Cyclic GMP; Endothelins; Fibrinolytic Agents; Humans; Microcirculation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation Inhibitors; Pyrazines; Vasoconstriction; Vasodilator Agents | 2002 |
8 other study(ies) available for tetramethylpyrazine and cyclic gmp
| Article | Year |
|---|---|
A possible mechanism of action of tetramethylpyrazine on vascular smooth muscle in rat aorta.
Topics: Animals; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phenethylamines; Potassium; Pyrazines; Rats; Rats, Inbred Strains; Theophylline; Vasodilation | 1989 |
Protective effect of tetramethylpyrazine against damages of aortic endothelial cells elicited by low-density lipoproteins.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Lipoproteins, LDL; Malondialdehyde; Pyrazines; Superoxide Dismutase | 1994 |
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.
Topics: Blood Platelets; Calcium; Cyclic GMP; Enzyme Activation; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Aggregation Inhibitors; Pyrazines | 2000 |
[Effect of chuanxiongzine on the relaxation of isolated rabbit corpus cavernosum tissues].
Topics: Animals; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Penis; Pyrazines; Rabbits | 2004 |
Role of cGMP signals in tetramethylpyrazine induced relaxation of the isolated rat aortic strip.
Topics: Animals; Aorta; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Guanylate Cyclase; In Vitro Techniques; Male; Pyrazines; Rats; Rats, Wistar; Vasodilation | 2005 |
Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits.
Topics: Animals; Basilar Artery; Blotting, Western; Calcium Signaling; Cerebral Angiography; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Endothelial Cells; Male; Microscopy, Confocal; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrazines; Rabbits; Signal Transduction; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vasospasm, Intracranial | 2010 |
Ligustrazine attenuates the platelet-derived growth factor-BB-induced proliferation and migration of vascular smooth muscle cells by interrupting extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways.
Topics: Arteriosclerosis; Becaplermin; Cell Movement; Cell Proliferation; Cyclic GMP; Gene Expression Regulation; Humans; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-sis; Pyrazines; Signal Transduction | 2015 |
A novel Danshensu/tetramethylpyrazine derivative induces vasorelaxation on rat aorta and exerts cardioprotection in dogs.
Topics: Animals; Arterial Pressure; Calcium; Cardiotonic Agents; Coronary Circulation; Cyclic GMP; Dogs; Extracellular Matrix; Intracellular Space; Lactates; Male; Myocardial Infarction; Nitric Oxide; Potassium Channels; Pyrazines; Rats; Receptors, Adrenergic, beta; Vasodilation; Vasodilator Agents | 2018 |